Gaps and Opportunities to Improve Prevention of Human Papillomavirus-related Cancers

The Society for Women’s Health Research (SWHR) published a paper in the Journal of Women’s Health, capturing the current landscape of HPV-related anogenital cancers, their effects on women’s health, and recommended areas in which to address gaps in primary and secondary prevention approaches to improve access and health outcomes for women. These insights were collected from a series of interdisciplinary meetings and events with expert researchers, clinicians, patient advocates, and health care policy leaders, convened by SWHR. 

Human papillomavirus (HPV) infections cause more than 35,900 cancers annually in the United States, with cervical cancer being the most prevalent HPV-related malignancy in women. While a comprehensive approach to mitigating cervical cancer includes HPV vaccination (primary prevention), screening and treatment of precancerous lesions (secondary prevention), and diagnosis and treatment of invasive cancer (tertiary prevention), there are still opportunities to innovate and increase access that can also be adapted to address the unique clinical care gaps that exist with the other anogenital cancers. 

READ THE FULL PAPER HERE

The Society for Women’s Health Research (SWHR) published a paper in the Journal of Women’s Health, capturing the current landscape of HPV-related anogenital cancers, their effects on women’s health, and recommended areas in which to address gaps in primary and secondary prevention approaches to improve access and health outcomes for women. These insights were collected from a series of interdisciplinary meetings and events with expert researchers, clinicians, patient advocates, and health care policy leaders, convened by SWHR. 

Human papillomavirus (HPV) infections cause more than 35,900 cancers annually in the United States, with cervical cancer being the most prevalent HPV-related malignancy in women. While a comprehensive approach to mitigating cervical cancer includes HPV vaccination (primary prevention), screening and treatment of precancerous lesions (secondary prevention), and diagnosis and treatment of invasive cancer (tertiary prevention), there are still opportunities to innovate and increase access that can also be adapted to address the unique clinical care gaps that exist with the other anogenital cancers. 

READ THE FULL PAPER HERE

More from SWHR about HPV

Event
#SWHRtalksHPV: Vaccination for Cancer Prevention
SWHR hosted a virtual public forum to share educational information about the HPV vaccine and highlight diverse perspectives on the value of the HPV vaccine in cancer prevention.
May 19, 2023 @ 12:30 pm - 1:45 pm EDT
Blog Post
Voicing Concern for the Rise in HPV-Associated Oral Cancers
Historically, oral cancer has been associated with smoking and alcohol consumption and diagnosed primarily in 60- and 70-year-old men. However, recently, HPV-associated oropharyngeal cancers increased by 1.3% in women each year.
HPV Vaccine Social Media Toolkit
As part of Sexually Transmitted Infections (STI) Awareness Month in April, SWHR created this toolkit to share out on social media tips for improving education around the HPV vaccine and its crucial role in public health.

This program was supported by an educational sponsorship from Inovio. SWHR maintains editorial control and independence over educational content.

This material was created by the Society for Women’s Health Research (SWHR) and is intended to serve as a public educational and informative resource. This material may be cited or shared on external channels, websites, and blogs, with attribution given to SWHR, or printed and displayed in its original formatted version. SWHR encourages the sharing and reposting of its content in order to spread awareness around women’s health issues. For specific questions about sharing SWHR content, please reach out to communications@swhr.org